MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Home・Aandelen Lijst・Avita Therapeutics Inc

Avita Therapeutics Inc

Gesloten

4.4 6.28

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.11

Max

4.53

Belangrijke statistieken
By Trading Economics
Inkomsten	-3.3M -13M
Verkoop	-1.4M 17M
Winstmarge	-77.289
Werknemers	260
EBITDA	-3.2M -11M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+8.96% upside

Dividenden
By Dow Jones
Volgende Winsten	12 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-2.1M 119M
Vorige openingsprijs	-1.88
Vorige sluitingsprijs	4.4

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

8.83 / 9.77 Steun & Weerstand

Avita Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 jan 2026, 18:41 UTC

Winsten

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

23 jan 2026, 22:30 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 jan 2026, 22:30 UTC

Marktinformatie

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 jan 2026, 22:03 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 jan 2026, 21:52 UTC

Winsten

Acquisities, Fusies, Overnames

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 jan 2026, 21:50 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

23 jan 2026, 21:39 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 jan 2026, 21:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 jan 2026, 21:12 UTC

Winsten

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 jan 2026, 20:31 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 jan 2026, 20:12 UTC

Marktinformatie

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 jan 2026, 20:07 UTC

Marktinformatie

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 jan 2026, 19:36 UTC

Marktinformatie

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 jan 2026, 19:30 UTC

Marktinformatie

Winsten

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 jan 2026, 19:18 UTC

Marktinformatie

Gold and Silver Step Up to More Records -- Market Talk

23 jan 2026, 19:15 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

23 jan 2026, 18:53 UTC

Marktinformatie

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

23 jan 2026, 18:21 UTC

Winsten

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

23 jan 2026, 18:19 UTC

Marktinformatie

Intel Seen as Increasingly Confident on Demand -- Market Talk

23 jan 2026, 17:59 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

23 jan 2026, 17:57 UTC

Marktinformatie

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

23 jan 2026, 17:57 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 jan 2026, 17:34 UTC

Marktinformatie

Winsten

Intel's Supply Challenges Seen Benefiting AMD -- Market Talk

23 jan 2026, 17:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

23 jan 2026, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

23 jan 2026, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

23 jan 2026, 17:13 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Avita Therapeutics Inc Prognose

Koersdoel

By TipRanks

8.96% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.5 USD 8.96%

Hoogste 5.5 USD

Laagste 3.5 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avita Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Avita Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

8.83 / 9.77Steun & Weerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.